Lifeway's revenue growth accelerated to 24.1% in 2026Q2 and 36.7% in 2026Q1, but this momentum appears increasingly costly: gross margin fell 1,080 basis points from 30.3% in 2025Q3 to 19.5% in 2026Q2, compressing operating margin to just 0.9% and net income to $127K—less than the quarter's $535K stock-based…
Price trend, volume and key moving averages
Trailing total returns as of 11/8/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q3 2026Latest Aug 13, 2026 | $0.01-96.2% vs $0.27 | $67M+8.9% vs $61M |
Q2 2026 May 14, 2026 | $0.30+0.0% vs $0.30 | $63M+3.6% vs $61M |
Q2 2026 Mar 17, 2026 | $0.16-44.8% vs $0.29 | $55M+0.7% vs $55M |
Q4 2025 Nov 12, 2025 | $0.23-17.9% vs $0.28 | $57M+3.9% vs $55M |
Lifeway Foods Named to Fortune's 100 Fastest-Growing Companies List, Ranking No. 45 in 2026PR NewswireMORTON GROVE, Ill., Oct. 26, 2026Leading Kefir and Probi
The company that pioneered frozen kefir is bringing elevated soft serve made with real kefir to froyo concepts in New York, Chicago, Los Angeles and beyond MORTON GROVE, Ill., Oct. 20, 2026 /PRNewswire/ -- Lifeway Foods, Inc. (Nasdaq: LWAY), the leading U.S. supplier of kefir, farmer cheese and fermented probiotic products, is bringing kefir back to soft-serve machines, giving restaurants and frozen yogurt shops a new way to serve the cultured dairy favorite.
Lifeway Foods NASDAQ: LWAY reported record second-quarter net sales of $66.9 million, up 24.1% from the prior-year period, as higher volumes of its flagship kefir products and high-protein Farmer Cheese supported growth.
$66.9 million in net sales, up 24.1% year-over-year and $3.9 million above the prior quarterly record 27th consecutive quarter of year-over-year net sales growth; first-half 2026 net sales reach $129.9 million, up 29.9% MORTON GROVE, Ill., Aug. 13, 2026 /PRNewswire/ -- Lifeway Foods, Inc. (Nasdaq: LWAY) ("Lifeway" or "the Company"), the leading U.S. supplier of kefir and fermented probiotic foods, today announced financial results for the second quarter ended June 30, 2026.
Benchmark LWAY against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Lifeway Foods, Inc. (LWAY)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $21.65 | $330.85M | 30.45 | 13.74% | 4.48% | 12.66% | — | |
| $89.83 | $1.68B | 34.18 | 0.54% | 3.23% | 5.4% | 3.46% | |
| $35.68 | $388.58M | 10.13 | 72.29% | 31.93% | 11.74% | 3.51% | |
| $12.05 | $1.07B | -6.84 | -6.51% | -11.49% | -10.23% | — | |
| $64.39 | $3.16B | 26.80 | 13.01% | 10.9% | 10.65% | — | |
| $0.15 | $13.48M | -0.04 | -13.23% | -22.53% | -106.47% | — |
Lifeway Foods, Inc. (LWAY) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Lifeway Foods, Inc. (LWAY) SEC filings — annual & quarterly reports (10-K, 10-Q)
Aug 13, 2026·SEC
Jul 7, 2026·SEC
Jun 18, 2026·SEC
Get notified when LWAY posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Lifeway Foods, Inc. (LWAY) stock FAQ — growth, dividends, profitability & financials explained
Lifeway Foods, Inc. (LWAY) reported $242.4M in revenue over the trailing twelve months. Revenue was $212.5M in fiscal year 2025. That is 3909% more than the $5.3M of fiscal year 1996.
Lifeway Foods, Inc. (LWAY) grew revenue by 25.6% over the trailing twelve months, compared with the twelve months before.
Yes. Lifeway Foods, Inc. (LWAY) earned $10.9M in net income over the trailing twelve months (a 4.5% net margin).
Lifeway Foods, Inc. (LWAY) had a return on equity (ROE) of 12.7% over the trailing twelve months. That is in line with the market's typical 10-15%.
Lifeway Foods, Inc. (LWAY) had negative free cash flow of $31.1M over the trailing twelve months.
